These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16441722)

  • 21. Application of a clinical magnet over implantable cardioverter defibrillators: is it safe and useful?
    Porres JM; Laviñeta E; Reviejo C; Brugada J
    Pacing Clin Electrophysiol; 2008 Dec; 31(12):1641-4; dicussion 1645. PubMed ID: 19067820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The use of implantable cardioverter-defibrillators (ICD) in children and adolescents].
    Apitz C; Gass M; Dörnberger V; Kuehlkamp V; Hofbeck M
    Klin Padiatr; 2006; 218(5):270-5. PubMed ID: 16947095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How to prevent ICD shocks: part II.
    Buck S; Maass AH; Van Gelder IC
    Europace; 2008 Sep; 10(9):1126-9. PubMed ID: 18710856
    [No Abstract]   [Full Text] [Related]  

  • 24. Narkomed 6400 anesthesia machine failure.
    Schulte TE; Tinker JH
    Anesth Analg; 2008 Mar; 106(3):1018-9; discussion 1019. PubMed ID: 18292459
    [No Abstract]   [Full Text] [Related]  

  • 25. Time shift of marker legend in stored intracardiac events in three patients with the vitality 2 EL DR (model T167) and Prizm 2DR (model 1861) dual-chamber defibrillators.
    Saba S; Jain S; Bazaz R; Schwartzman D
    J Cardiovasc Electrophysiol; 2009 May; 20(5):564-7. PubMed ID: 19054249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inappropriate shocks or inappropriate programming? A review of Guidant's reconfirmation algorithm.
    Mansour F; Guash E; Berruezo A; Brugada J; Tolosana JM; Mont L
    Europace; 2009 Aug; 11(8):1120-2. PubMed ID: 19443435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implantable defibrillator with left ventricular assist device compatibility.
    Oswald H; Klein G; Strüber M; Gardiwal A
    Interact Cardiovasc Thorac Surg; 2009 May; 8(5):579-80. PubMed ID: 19223309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The top 10 reasons to avoid defibrillation threshold testing during ICD implantation.
    Viskin S; Rosso R
    Heart Rhythm; 2008 Mar; 5(3):391-3. PubMed ID: 18313596
    [No Abstract]   [Full Text] [Related]  

  • 29. T-wave oversensing in implantable cardiac defibrillators is due to technical failure of device sensing.
    Gilliam FR
    J Cardiovasc Electrophysiol; 2006 May; 17(5):553-6. PubMed ID: 16684033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shocking truths about implantable cardioverter defibrillator monitoring zones.
    Mansour F; Thibault B; Dubuc M; Guerra PG; Macle L; Brugada R; Roy D; Talajic M; Khairy P
    Pacing Clin Electrophysiol; 2007 Sep; 30(9):1146-8. PubMed ID: 17725760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety summary: Defibrillators.
    Health Devices; 2012 May; 41(5):157-8. PubMed ID: 23441428
    [No Abstract]   [Full Text] [Related]  

  • 32. Implantable cardiac defibrillator lead failure or myopotential oversensing? An approach to the diagnosis of noise on lead electrograms.
    Kowalski M; Ellenbogen KA; Wood MA; Friedman PL
    Europace; 2008 Aug; 10(8):914-7. PubMed ID: 18565976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrosurgery on patients with implantable cardioverter-defibrillators.
    Health Devices; 2002 Feb; 31(2):74. PubMed ID: 11898682
    [No Abstract]   [Full Text] [Related]  

  • 34. Implantable stimulator failures: causes, outcomes, and solutions.
    Liu X; Demosthenous A; Donaldson N
    Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():5787-90. PubMed ID: 18003328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient Alert to detect ICD lead failure: efficacy, limitations, and implications for future algorithms.
    Vollmann D; Erdogan A; Himmrich E; Neuzner J; Becker D; Unterberg-Buchwald C; Sperzel J
    Europace; 2006 May; 8(5):371-6. PubMed ID: 16635998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Relation of defibrillation threshold on shock duration and discharge capacity. Determination of chronoaxis-rheobase relations of defibrillators].
    Wagner SM; Lawo T; Rosada B; Kuschkowitz F; Buddensiek M; Schrader J; Schaldach M
    Biomed Tech (Berl); 1998; 43 Suppl():358-9. PubMed ID: 9859397
    [No Abstract]   [Full Text] [Related]  

  • 37. Tools and strategies for the reduction of inappropriate implantable cardioverter defibrillator shocks.
    Tzeis S; Andrikopoulos G; Kolb C; Vardas PE
    Europace; 2008 Nov; 10(11):1256-65. PubMed ID: 18708639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Optimizing 2-electrode arrays of implantable defibrillators].
    Wurtz S; Müller M; Meyer-Waarden K
    Biomed Tech (Berl); 1998; 43 Suppl():374-5. PubMed ID: 9859405
    [No Abstract]   [Full Text] [Related]  

  • 39. Re: "Strategy to eliminate inappropriate shocks secondary to T-wave oversensing in a biventricular ICD".
    Alsheikh T
    Pacing Clin Electrophysiol; 2009 Jul; 32(7):963; author reply 963. PubMed ID: 19572881
    [No Abstract]   [Full Text] [Related]  

  • 40. Multiple ICD discharges associated with lead fracture without triggering of high impedance alert.
    Donaldson DM; Singh JP; Heist EK; Mela T; Ruskin JN; Das S
    Pacing Clin Electrophysiol; 2009 Apr; 32(4):543-6. PubMed ID: 19335867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.